Skip to main content

Table 2 Patient characteristics (n = 94)

From: From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience

Characteristics Whole set of patients (n = 94) Complete CCRT (n = 41) Incomplete CCRT (n = 53) p-value
Age, years, median (IQR) 63.0 (51.3–75.0) 59.1 (50.7–73.4) 65.3 (54.4–76.0) NS
PS, n (%)     
PS ≤ 1 83 (88.3) 24 (58.5) 20 (37.7) 0.03a
PS ≥ 2 10 (10.6) 16 (39.0) 33 (62.3)  
UK 1 (1.1) 1 (2.4) 0 (0)  
Charlson combined age-comorbidity index, n (%)     
 0 9 (9.6) 4 (9.8) 5 (9.4) NS
 1–2 29 (30.9) 16 (39.0) 13 (24.5)  
 3–4 31 (33.0) 13 (31.7) 18 (34.0)  
 ≥ 5 25 (26.6) 8 (19.5) 17 (32.1)  
Quintile EDI     
 1 8 (8.5) 4 (9.8) 4 (7.5) NS
 2 15 (16.0) 8 (19.5) 7 (13.2)  
 3 11 (11.7) 2 (4.9) 9 (17.0)  
 4 24 (25.5) 14 (34.1) 10 (18.9)  
 5 29 (30.9) 11 (26.8) 18 (34.0)  
 UK 7 (7.4) 2 (4.9) 5 (9.4)  
Histological type, n (%)     
 Squamous cell carcinoma 72 (76.6) 33 (80.5) 39 (73.6) NS
 Adenocarcinoma 14 (14.9) 6 (14.6) 8 (15.1)  
 Other 8 (8.6) 2 (4.9) 6 (11.3)  
Differentiation grade, n (%)     
 High 24 (25.5) 12 (29.3) 12 (22.6) NS
 Moderate 26 (27.7) 12 (29.3) 14 (26.4)  
 Low 32 (34.0) 12 (29.3) 20 (37.7)  
 UK 12 (12.8) 5 (12.2) 7 (13.2)  
FIGO Stage, n (%)     
 IB2 10 (10.6) 5 (12.2) 5 (9.4) NS
 IIA 21 (22.3) 15 (36.6) 16 (30.2)  
 IIB 48 (51.0) 19 (46.3) 29 (54.7)  
 IIIA 4 (4.3) 0 (0) 4 (7.5)  
 IIIB 11 (11.7) 7 (17.1) 4 (7.5)  
Largest MRI tumour diameter, n (%)     
 < 4 cm 28 (29.8) 13 (31.7) 15 (28.3) NS
 4 to 6 cm 27 (27.7) 12 (29.3) 14 (26.4)  
 > 6 cm 15 (22.3) 4 (9.8) 11 (20.8)  
 UK 24 (25.5) 10 (24.4) 14 (26.4)  
Lymph node involvement according to initial workup, n (%)     
 Pelvic 32 (34.0) 13 (31.7) 19 (35.8) NS
 Para-aortic 0 (0) 0 (0) (0)  
Initial workup, n (%)     
 Pelvic MRI 87 (92.6) 40 (97.6) 47 (94.0) NS
 Cystoscopy 33 (35.1) 15 (37.5) 18 (36.7) NS
 PET-CT 31 (33.0) 11 (28.9) 20 (40.0) NS
Initial haemoglobin, g/dL, median (IQR) 12.9 (11.9–14.2) 13.1 (12.3–14.2) 12.8 (11.5–13.9) NS
  1. Lymph node involvement is assessed according to the initial workup
  2. Abbreviations: CCRT Concomitant Chemoradiotherapy, IQR Interquartile Range, PS Performance Status, UK Unknown, EDI European Deprivation Index, FIGO International Federation of Gynaecology and Obstetrics, MRI Magnetic Resonance Imaging, PET-CT Positron Emission Tomography-Computed Tomography
  3. aChi square test